Clinical Professor of Neurology, Director of University of Cincinnati Neuroscience Institute, University Cincinnati
Neurology
Dr. Joseph P. Broderick, MD
|
|
Give Review
Joseph Broderick works in the field of Neurology. He went to medical school at University of Cincinnati College of Medicine. He over the years received 3 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "Top MD". Joseph Broderick is also a published doctor. He has 97 paper published. The most recent paper is: Incontinence and gait disturbance after intraventricular extension of intracerebral hemorrhage. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- The National Institutes of Health StrokeNet: A User's Guide.
- Incontinence and gait disturbance after intraventricular extension of intraCerebral hemorrhage.
- Withdrawal of Antithrombotic Agents and the Risk of Stroke.
- Endovascular revascularization results in IMS III: intraCranial ICA and M1 occlusions.
- Organizational update: american heart association stroke council.
- Challenges of Decision Making Regarding Futility in a Randomized Trial: The Interventional Management of Stroke III Experience.
- Meta-analysis of Genome-wide Association Studies Identifies 1q22 as a Susceptibility Locus for IntraCerebral Hemorrhage.
- American Stroke Association Stroke Council Update.
- Profiles of the national institutes of health stroke scale items as a predictor of patient outcome.
- Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke: A Consensus Statement.
- Review, Historical Context, and Clarifications of the NINDS rt-PA Stroke Trials Exclusion Criteria: Part 1: Rapidly Improving Stroke Symptoms.
- Acute Stroke Imaging Research Roadmap II.
- Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke-Enhanced Regimen Stroke Trial.
- Diabetes mellitus: a risk factor for ischemic stroke in a large biracial population.
- RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke.
- Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke.
- Common Variants Within Oxidative Phosphorylation Genes Influence Risk of Ischemic Stroke and IntraCerebral Hemorrhage.
- Synchronous x-ray and radio mode switches: a rapid global transformation of the pulsar magnetosphere.
- Familial intracranial Aneurysms: is anatomic vulnerability heritable?
- Risk factors for intraCerebral hemorrhage differ according to hemorrhage location.
- Carotid Artery Stenosis as a Cause of Stroke.
- Parenchymal hematoma and total lesion volume in combined IV/IA revascularization stroke therapy.
- Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of Cerebral ischemia and reperfusion.
- Antihypertensives Are Administered Selectively in Emergency Department Patients with Subarachnoid Hemorrhage.
- Toward a Modern Delivery of Stroke Care in Emerging Economies.
- Effects of gender on gene expression in the blood of ischemic stroke patients.
- Variability in the Use of Intravenous Thrombolysis for Mild Stroke: Experience Across the SPOTRIAS Network.
- Acute stroke therapy at the crossroads.
- The X-Chromosome Has a Different Pattern of Gene Expression in Women Compared With Men With Ischemic Stroke.
- The practice of Carotid revascularization in a large metropolitan population.
- Letter by Hill et al Regarding Article, "A Cost-Utility Analysis of Mechanical Thrombectomy as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute La...
- The challenges of intraCranial revascularization for stroke prevention.
- Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurrence.
- Is ED disposition associated with intraCerebral hemorrhage mortality?
- Efficiency of Enrollment in a Successful Phase II Acute Stroke Clinical Trial.
- Assessing stroke incidence and mortality across the United States.
- Patient-level and hospital-level determinants of the quality of acute stroke care: a multilevel modeling approach.
- Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials.
- Signatures of cardioembolic and large-vessel ischemic stroke.
- How much would performing diffusion-weighted imaging for all transient ischemic attacks increase MRI utilization?
- Definition of delayed cerebral ischemia after Aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multid...
- Gene expression profiling of blood for the prediction of ischemic stroke.
- Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Ken...
- Which stroke symptoms prompt a 911 call? A population-based study.
- Anti-N-methyl-D-aspartate receptor encephalitis: characteristic behavioral and movement disorder.
- Thromboembolic events with recombinant activated factor VII in spontaneous intraCerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) ...
- Temporal trends in public awareness of stroke: warning signs, risk factors, and treatment.
- The challenge of designing a treatment trial for warfarin-associated intraCerebral hemorrhage.
- Evidence against rapid reversal of antiplatelet medications in acute intraCerebral hemorrhage.
- Mechanical reperfusion is associated with post-ischemic hemorrhage in rat Brain.
- Endovascular therapy for acute ischemic stroke.
- Age at intracranial Aneurysm rupture among generations: Familial Intracranial Aneurysm Study.
- Smoking and family history and risk of Aneurysmal subarachnoid hemorrhage.
- Seizures are common in the acute setting of childhood stroke: a population-based study.
- Surgical management and case-fatality rates of intraCerebral hemorrhage in 1988 and 2005.
- How important is surrogate consent for stroke research?
- Use of intravenous tissue plasminogen activator in a 16-year-old patient with basilar occlusion.
- Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke.
- Incidence of seizures in the acute phase of stroke: a population-based study.
- Reperfusion activates metalloproteinases that contribute to neurovascular Injury.
- Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intraCerebral hemorrhage.
- National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate.
- Designing a message for public education regarding stroke: does FAST capture enough stroke?
- The role of race in time to treatment after subarachnoid Hemorrhage.
- Intracranial Hemorrhage associated with revascularization therapies.
- Emergency department arrival times after acute ischemic stroke during the 1990s.
- Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study.
- Community socioeconomic status and prehospital times in acute stroke and transient ischemic attack: do poorer patients have longer delays from 911 call to the emergenc...
- Location and outcome of anticoagulant-associated intraCerebral hemorrhage.
- Potential applicability of recombinant factor VIIa for intraCerebral hemorrhage.
- Smoking cessation after stroke: education and its effect on behavior.
- Perimesencephalic subarachnoid Hemorrhage: incidence, risk factors, and outcome.
- Genetic epidemiology of intraCerebral hemorrhage.
- Validity of a retrospective National Institutes of Health Stroke Scale scoring methodology in patients with severe stroke.
- Major risk factors for intraCerebral hemorrhage in the young are modifiable.
- The STICH trial: what does it tell us and where do we go from here?
- Risk of thrombolysis-associated intraCerebral hemorrhage: the need to compare apples with apples.
- Racial variations in location and risk of intraCerebral hemorrhage.
- Incidence and short-term prognosis of transient ischemic attack in a population-based study.
- Advances in the treatment of hemorrhagic stroke: a possible new treatment.
- A description of Canadian and United States physician reimbursement for thrombolytic therapy administration in acute ischemic stroke.
- Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study.
- Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intraCerebral hemorrhage: a case-control study.
- tPA and proteolysis in the neurovascular unit.
- Intravenous thrombolysis for acute stroke.
- William M. Feinberg Lecture: stroke therapy in the year 2025: burden, breakthroughs, and barriers to progress.
- The effect of race and gender on patterns of rt-PA use within a population.
- Trends in community knowledge of the warning signs and risk factors for stroke.
- Natural history of perihematomal edema in patients with hyperacute spontaneous intraCerebral hemorrhage.
- Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intraCerebral hemorrhage.
- Treatment of acute ischemic stroke: Part II: neuroprotection and medical management.
- Treatment of acute ischemic stroke: Part I: recanalization strategies.
- Isoforms of apolipoprotein E can modulate tPA-induced clot lysis in vitro.
- Spontaneous intraCerebral hemorrhage: epidemiology and clinical presentation.
- Genetic and environmental risk factors for intraCerebral hemorrhage: preliminary results of a population-based study.
- Acute Ischemic Stroke with Very Early Clinical Improvement: A National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke T...
Schools
University Of Cincinnati College Of Medicine
Mayo Clinic Rochester
Mayo Clinic
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
- Non-Cosmetic Chemodenervation
Conditions Treated
- Alzheimer's Disease
- Anterior Horn Disease
- Ataxia
- Autonomic Disorders
- View All
Doctors Specialties
- Vascular Neurology
- Neurology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medical Mutual of Ohio POS
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Sagamore Plus
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Top MD
Education
-
Mayo School of Graduate Medical Education -
University of Cincinnati College of Medicine
Hospital
-
Christ Hospital -
University of Cincinnati Medical Center
Drug Facts
| NPI NUMBER | 1609817642 | |
| NPPES Provider LastName | BRODERICK | |
| NPPES Provider FirstName | JOSEPH | |
| NPPES Provider ZIPCode | 452194231 | |
| NPPES Provider State | OH | |
| Specialty Description | Neurology | |
| Total Claim Count | 601.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609817642 |
| Last Name Of The Provider | BRODERICK |
| First Name Of The Provider | JOSEPH |
| View All |
Similar Doctors
|
Dr. Robert L. Reed, MD |
|
Dr. Onassis A. Caneris, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Woo, MD |
|
|
Dr. Laura A. Sams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brett M. Kissela, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Darcy A. Krueger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew L. Flaherty, MD |
|
|
Dr. Sheetal Malik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samir Belagaje, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marielle A. Kabbouche, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel S. Kanter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle C. Bowman, MD |
|
|
Dr. Simona Ferioli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Holli A. Horak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erik Sass, MD |
|
|
Dr. Joao M. Plancher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Blake A. Smith, MD |
|
|
Mike T. Lanou |
|
|
Christine F. Wassler |